Janney Montgomery Scott LLC lifted its stake in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 2.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,865 shares of the medical equipment provider’s stock after purchasing an additional 197 shares during the period. Janney Montgomery Scott LLC’s holdings in Integer were worth $1,307,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. Eagle Asset Management Inc. bought a new stake in Integer in the third quarter worth $14,403,000. Bamco Inc. NY boosted its stake in shares of Integer by 17.4% during the 3rd quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider’s stock worth $33,069,000 after acquiring an additional 37,700 shares in the last quarter. Jane Street Group LLC increased its holdings in shares of Integer by 23.3% during the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after acquiring an additional 28,572 shares during the last quarter. Point72 DIFC Ltd bought a new position in shares of Integer in the 3rd quarter valued at approximately $2,977,000. Finally, Edgestream Partners L.P. acquired a new stake in Integer in the 3rd quarter worth approximately $2,894,000. 99.29% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on ITGR shares. Citigroup lifted their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. KeyCorp lifted their price objective on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company restated an “overweight” rating and set a $160.00 target price on shares of Integer in a research note on Tuesday, December 3rd. Piper Sandler reaffirmed an “overweight” rating and issued a $140.00 price target (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Finally, Benchmark increased their price objective on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $146.56.
Integer Stock Up 0.9 %
NYSE ITGR opened at $139.44 on Wednesday. Integer Holdings Co. has a 1-year low of $94.56 and a 1-year high of $146.36. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The stock’s 50 day moving average is $137.90 and its two-hundred day moving average is $130.70. The company has a market capitalization of $4.68 billion, a price-to-earnings ratio of 43.04, a PEG ratio of 1.81 and a beta of 1.13.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Read More
- Five stocks we like better than Integer
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Most Volatile Stocks, What Investors Need to Know
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.